Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LM7P
|
||||
Former ID |
DNC011562
|
||||
Drug Name |
(D)Arg-Arg-Pro-Hyp-Gly-Phe-Ser-(d)Phe-Phe-Arg
|
||||
Indication | Discovery agent | Investigative | [529475] | ||
Structure |
Download2D MOL |
||||
Formula |
C60H87N19O13
|
||||
Canonical SMILES |
C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N<br />2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)NC(C<br />C4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=<br />O)O)O
|
||||
InChI |
1S/C60H87N19O13/c61-39(20-10-24-68-58(62)63)49(83)73-40(21-11-25-69-59(64)65)55(89)78-27-13-23-46(78)56(90)79-33-38(81)31-47(79)54(88)71-32-48(82)72-42(28-35-14-4-1-5-15-35)50(84)77-45(34-80)53(87)76-44(30-37-18-8-3-9-19-37)52(86)75-43(29-36-16-6-2-7-17-36)51(85)74-41(57(91)92)22-12-26-70-60(66)67/h1-9,14-19,38-47,80-81H,10-13,20-34,61H2,(H,71,88)(H,72,82)(H,73,83)(H,74,85)(H,75,86)(H,76,87)(H,77,84)(H,91,92)(H4,62,63,68)(H4,64,65,69)(H4,66,67,70)/t38?,39-,40-,41?,42+,43?,44?,45?,46-,47-/m0/s1
|
||||
InChIKey |
RBIXVHPHNGXTCI-QWTWDILDSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | B2 bradykinin receptor | Target Info | Inhibitor | [529475] | |
KEGG Pathway | Calcium signaling pathway | ||||
cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Complement and coagulation cascades | |||||
Inflammatory mediator regulation of TRP channels | |||||
Regulation of actin cytoskeleton | |||||
Endocrine and other factor-regulated calcium reabsorption | |||||
Chagas disease (American trypanosomiasis) | |||||
Pathways in cancer | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Direct p53 effectors | ||||
Validated transcriptional targets of deltaNp63 isoforms | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.